The results of several studies have shown that PDPN is involved in ECM remodeling, and that the process of ECM degradation predominantly involves MMP-2 and MMP-9 whose expression correlates with prognosis in some cancer types [24, 47–52]. This evidence concerns the gene MMP9 and cancer.